IQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should KnowZacks Investment Research · 2 days ago
IQVIA: R&D Bookings Are Reaccelerating, But The Valuation Now Requires ExecutionSeeking Alpha · 4 days ago
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?Zacks Investment Research · 4 days ago
IQVIA Holdings Inc. $IQV Stock: Maia Wealth LLC Reduces StakeDefense World · 5 days ago
First Citizens Bank & Trust Co. Makes New $1.39 Million Investment in IQVIA Holdings Inc. $IQVDefense World · Oct 16, 2026
IQVIA Selects Veeva Clinical Operations ApplicationsPRNewsWire · Oct 13, 2026IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 28, 2026 | $3.03 | $3.15 | Beat |
| May 5, 2026 | $2.82 | $2.90 | Beat |
| Feb 5, 2026 | $3.40 | $3.42 | Beat |
| Oct 28, 2025 | $2.98 | $3.00 | Beat |
| Jul 22, 2025 | $2.77 | $2.81 | Beat |
| May 6, 2025 | $2.63 | $2.70 | Beat |